CRO model with target exclusivity
In the CRO-type partnership we provide target-exclusive services to customers from the pharmaceutical industry. The project IP is fully owned by the customer.
Structure based drug discovery of leadXpro therapeutics
In the biotech business model we generate and characterize drug candidates for partnering with pharmaceutical companies in clinical research. Therapeutic areas are oncology, inflammation and antibiotics.